GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Towa Pharmaceutical Co 4553.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

3,375

+1.96%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥273.71bn

FY2017FY2026

Net income

¥5.25bn

FY2017FY2026

Free cash flow

¥8.15bn

FY2017FY2026

Shareholders' equity

¥178.10bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥273.71bn¥259.59bn¥227.93bn¥208.86bn¥165.62bn¥154.90bn¥110.38bn¥105.10bn¥93.43bn¥84.95bn
Gross profit¥99.10bn¥94.73bn¥81.38bn¥72.71bn¥70.19bn¥65.45bn¥50.65bn¥48.40bn¥43.05bn¥39.05bn
Research and development—¥16.21bn¥13.24bn¥15.27bn¥11.49bn¥10.64bn¥8.57bn¥7.92bn¥7.72bn¥9.35bn
Operating income¥23.10bn¥24.65bn¥18.50bn¥5.51bn¥18.76bn¥19.93bn¥16.17bn¥16.28bn¥11.64bn¥7.14bn
Net income¥5.25bn¥18.99bn¥16.17bn¥2.20bn¥15.91bn¥13.96bn¥14.50bn¥13.47bn¥6.50bn¥5.58bn
Diluted earnings per share106.65385.67328.5444.72323.31277.36288.23253.41122.16104.87

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥475.29bn¥470.82bn¥430.65bn¥371.35bn¥332.10bn¥245.67bn¥230.02bn¥189.16bn¥177.66bn¥165.25bn
Cash and short-term investments¥45.31bn¥45.47bn¥29.65bn¥24.26bn¥32.83bn¥22.91bn¥18.71bn¥31.76bn¥25.25bn¥17.29bn
Total liabilities¥297.18bn¥299.19bn¥274.76bn¥234.45bn¥199.93bn¥129.07bn¥125.35bn¥97.39bn¥97.73bn¥90.30bn
Debt¥226.74bn¥230.98bn¥202.36bn¥161.52bn¥140.70bn¥82.39bn¥82.39bn¥67.08bn¥64.95bn¥65.42bn
Shareholders' equity¥178.10bn¥171.63bn¥155.89bn¥136.89bn¥132.17bn¥116.60bn¥104.67bn¥91.77bn¥79.92bn¥74.94bn
Shares outstanding49m49m49m49m49m50m50m53m53m53m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥30.43bn¥23.40bn¥8.21bn¥2.54bn¥22.13bn¥12.01bn¥19.16bn¥19.00bn¥19.23bn¥10.20bn
Capital spending−¥22.28bn−¥28.74bn−¥37.85bn−¥28.73bn−¥11.14bn−¥9.14bn−¥4.55bn−¥11.14bn−¥14.48bn−¥20.49bn
Free cash flow¥8.15bn−¥5.33bn−¥29.64bn−¥26.19bn¥10.99bn¥2.87bn¥14.62bn¥7.86bn¥4.75bn−¥10.29bn
Dividends paid−¥3.94bn−¥2.95bn−¥2.95bn−¥3.10bn−¥2.41bn−¥2.17bn−¥2.07bn−¥1.56bn−¥1.56bn−¥1.56bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥71.38bn¥69.64bn¥73.59bn¥65.33bn¥65.15bn¥65.86bn¥70.33bn¥60.84bn
Gross profit¥26.10bn¥23.98bn¥27.91bn¥23.53bn¥23.68bn¥23.98bn¥25.83bn¥21.57bn
Operating income¥6.52bn¥3.61bn¥9.05bn¥5.24bn¥5.21bn¥4.63bn¥8.10bn¥4.84bn
Net income¥5.53bn−¥11.83bn¥8.87bn¥5.70bn¥2.51bn¥4.36bn¥8.07bn¥1.06bn
Diluted earnings per share112.35-240.35180.14115.8151.0588.61163.9121.53
Cash from operations¥729.0m¥17.31bn−¥969.0m¥8.20bn¥5.89bn¥17.71bn−¥2.96bn¥14.55bn
Capital spending−¥3.08bn−¥4.61bn−¥5.32bn−¥8.42bn−¥4.38bn−¥6.83bn−¥10.34bn−¥10.33bn
Free cash flow−¥2.36bn¥12.69bn−¥6.28bn−¥223.0m¥1.51bn¥10.88bn−¥13.30bn¥4.22bn
Total assets¥480.71bn¥475.29bn¥488.89bn¥480.53bn¥475.23bn¥470.82bn¥459.00bn¥442.84bn
Cash and short-term investments¥42.23bn¥45.31bn¥39.82bn¥49.58bn¥52.94bn¥45.47bn¥29.25bn¥41.27bn
Debt¥33.53bn¥213.91bn¥32.18bn¥223.27bn¥29.41bn¥219.18bn¥16.72bn¥214.18bn
Shareholders' equity¥182.48bn¥178.10bn¥189.69bn¥179.86bn¥172.72bn¥171.63bn¥169.02bn¥159.11bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.4%12.1%12.8%
Operating income61.2%3.0%7.6%
Net income33.6%-17.8%-3.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin36.3%35.9%37.5%40.0%
Operating margin9.0%7.4%8.6%9.8%
Net margin4.5%4.4%5.6%6.8%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings34.29.410.252.66.610.36.611.220.919.6
Price to sales0.70.70.70.60.60.90.91.41.41.3

Dividends and splits

Per share, in the currency the company pays

Paid for 34 years. Last went ex-dividend on 29 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year40.00120.0060.0060.0063.0025.0044.0042.00
  • 3-for-1 split · 27 Mar 2019
  • 1.1-for-1 split · 26 Mar 1996
  • 1.1-for-1 split · 28 Mar 1995

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.